ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HVO Hvivo Plc

26.70
-0.55 (-2.02%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.55 -2.02% 26.70 26.00 27.00 27.25 26.25 27.25 2,589,827 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 48.48M -776k -0.0011 -240.91 178.9M
Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 27.25p. Over the last year, Hvivo shares have traded in a share price range of 14.15p to 31.00p.

Hvivo currently has 675,075,857 shares in issue. The market capitalisation of Hvivo is £178.90 million. Hvivo has a price to earnings ratio (PE ratio) of -240.91.

Hvivo Share Discussion Threads

Showing 1826 to 1847 of 9975 messages
Chat Pages: Latest  75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
12/9/2018
08:47
mam fach. Clearly the institutions are in the loop unlike the pi. They have managed to accumulate even though the company gave the market the impression that news was due in or around July. The Woodford Group have not thought 'Oh, lets load up until we get further updates' Imo, they have increased in a measured calculating way and used the perception of a delay to get a discount. I cannot see them or Invesco panicking when the share price drops. It suits their agenda. I suppose it's not their money anyway.
Just my thoughts and my opinion but I'm happy to hold and feeling very confident that the share price will significantly rerate when the company updates the market.

leas1
11/9/2018
10:00
Holders selling as they are loosing faith.
Certainly share has great potential - but when?

mam fach
10/9/2018
15:27
Unbelievable how holders have sold into this demand.Stunning really.Under 30% available to Joe soap
billthebank
10/9/2018
09:35
RNS today confirms my suspicions that Woody is back to buying on the open market now as the supply from Griffiths has dried up. Hopefully PIs see this and don't indulge him as the tight free float means he will only have to pay more and more each time he adds.
bernymadoff
08/9/2018
10:02
Apple you've clearly had too much cider it's clouding your judgement.
The malaria trial is ongoing. It's easy to check on the NiH website according to which it will end in August 2019. The primary completion date is given as Oct 2018. Like I've said repeatedly here in the short and medium term this is now all about Flu-v and getting it sold to one of the majors.

bernymadoff
07/9/2018
17:55
Big £56k order showing up today at 63p. That would explain the book flipping on Wednesday and the share price strength since. My guess is that Woody is having to buy on the open market because Griffiths has sold out or is not selling any more. There's such a right free float here and such low liquidity that it's taken 3 days to fill the order.

Leas, you are spot on about the institutions taking the most value here. They are loading up on the cheap aware of the bigger picture while stupid PIs fret over every little movement up or down.

Looking forward to the next update whether that's the remaining results or the interims which I am pretty sure will contain some kind of update about the progress of commercialisation negotiations. Remember it's been almost 3 months since the company said Flu-V is P3 ready and they will be talking to ALL the majors and I can't imagine they've been sitting on their hands since.

Oh and the directors have made sure to fill their boots by exercising their options so that they can take advantage of the big payday coming up.

bernymadoff
07/9/2018
13:08
'lose lots of money. lol' Don't tell me you would get satisfaction from that? If the share price tanked by 100% then that would be zero. Zika compound showing positive progress and any update on any one of their developments will further boost the MC. Many forget that HVO are not a 'one trick pony'.

Enjoy your weekend apple. Isn't September that apples get squeezed into juice? Be careful you don't fall into a cider press. :(

leas1
07/9/2018
12:49
If mosquito test results are bad and issued before late flu results here this could tank 100% many mugs could be looking at sub 30p if that's the case so any decent rise on flu results would be wiped out here ! This is very very risky and many mugs are gonna lose a lot of money lol
applegarthlse
06/9/2018
15:05
Likewise Bill. Although I am locked in as I bought outside of my investment ISA at a very good average prior to FLU-5 update. The current Mrs leas is maxed out too after I flipped half of my holding back in June. Many pi's will look to take a profit (on expected news) so expect a small pullback after the herd moves on. Value will be for the LTH's who will more than likely be the institutions.
leas1
06/9/2018
14:37
Yeah I noticed the spread and obviously there arent many shares being traded as there aren't many available, When news is released this will go berserk All depends on the news of coure!!! I have extremely strong expectations here and if it goes as I expect this will be a long term hold for me.
billthebank
06/9/2018
14:34
Bill :) I just put it down to lack of liquidity. I also think the recent pullback has been measured and calculated. Enough to change sentiment but not enough to drop it and see a stampede to buy. The spread is keeping the lid on it atm, buyers have to pay a premium.
Apple is quiet, must be a good sign.

leas1
05/9/2018
18:00
disco, I have been tempted but he does make me smile. Clearly been 'drawn' to an investment based on a comment on a bb without doing his own research. AIM full of them sadly. Rainbow chasing poker players.
I'm sure he's harmless. If anyone sells based on his comments then they must be as mad he is.

leas1
05/9/2018
17:03
Finally filtered that cretin. Genuinely wonder if hes lost £1000s on this share or just a fruitcake, I'll probably never know
discojames
05/9/2018
13:45
No there's just more mug muppets lining up to blow three money on this shi7 today lol
applegarthlse
05/9/2018
13:34
Interesting turnaround here. Gone blue and MMs will take 30k off me at above bid.

Is good news coming?

bernymadoff
05/9/2018
13:20
full ask to buy anything of any size now
bernymadoff
05/9/2018
13:07
RAMPING PIG ! THIS IS DOG SHI7
applegarthlse
05/9/2018
13:06
NT to buy anything now over £1000. Could this be turning?

I would expect the company to give an update about commercialisation of Flu-V in the upcoming interims.

bernymadoff
05/9/2018
10:19
Only muggy punters gambling on this now lol
applegarthlse
05/9/2018
10:07
How many times have you seen the MM's drop a share just before news? Ignore the noise and focus on the big prize.

Found this today. Apologies if it's already been posted but looks like Gregory Stoloff is just the man to lead us into a deal with a major pharma.


"Gregory A Stoloff is CEO of SEEK. He founded the company – formerly known as PepTcell – in 2004 after a distinguished career in investment banking spanning 20 years, working in a broad range of institutions including Deutsche Bank and UBS. He initially concentrated on corporate finance and was involved in numerous mergers and acquisitions and structured finance with an emphasis on the healthcare industry, including mergers by GlaxoSmithKline, Aventis and Pfizer. Gregory then moved on to concentrate on project finance and was involved in financing for pharmaceutical companies such as Roche, Merck and Novartis and companies in various other sectors. Gregory also has a wealth of experience in advising and working with medical research companies.

He is a qualified chartered accountant and has spent many years researching scientific medical issues, specifically related to the immune system. He has also been involved in several publications, recounting research in the peptide space and is listed as an inventor in numerous patents for cancer, HIV, mosquito-borne diseases and influenza."




hxxps://pharmaphorum.com/views-and-analysis/interview-medical-mastermind-gregory-stoloff/

bernymadoff
05/9/2018
08:28
risky business averaging down on this falling knife ?
mister md
04/9/2018
20:43
Nice £18k buy into close today.

I topped up today as I think the bottom is in. Someone else obviously thinks the same

bernymadoff
Chat Pages: Latest  75  74  73  72  71  70  69  68  67  66  65  64  Older

Your Recent History

Delayed Upgrade Clock